(Q51396553)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27737921%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

review article

1 reference

title

Relevance of Tumor-Infiltrating Immune Cell Composition and Functionality for Disease Outcome in Breast Cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27737921%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27737921%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Rudolf Fehrmann

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27737921%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

4

John B A G Haanen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27737921%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

author name string

Rico D Bense

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27737921%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Christos Sotiriou

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27737921%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Martine J Piccart-Gebhart

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27737921%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Marcel A T M van Vugt

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27737921%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Carolien P Schröder

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27737921%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

language of work or name

English

0 references

publication date

13 October 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27737921%20AND%20SRC:MED&resulttype=core&format=json

Journal of the National Cancer Institute

25 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27737921%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

volume

109

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27737921%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27737921%20AND%20SRC:MED&resulttype=core&format=json

Predictors of resistance to preoperative trastuzumab and vinorelbine for HER2-positive early breast cancer

25 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW192

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW192

Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: BIG 02-98

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW192

Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW192

Tumor-Infiltrating Lymphocytes and Associations With Pathological Complete Response and Event-Free Survival in HER2-Positive Early-Stage Breast Cancer Treated With Lapatinib and Trastuzumab: A Secondary Analysis of the NeoALTTO Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW192

Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW192

Tumor-infiltrating lymphocytes are correlated with response to neoadjuvant chemotherapy in triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW192

Tumor-infiltrating lymphocytes and response to neoadjuvant chemotherapy with or without carboplatin in human epidermal growth factor receptor 2-positive and triple-negative primary breast cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW192

Proliferating macrophages associated with high grade, hormone receptor negative breast cancer and poor clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW192

High-infiltration of tumor-associated macrophages predicts unfavorable clinical outcome for node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW192

An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW192

Genomic analysis reveals that immune function genes are strongly linked to clinical outcome in the North Central Cancer Treatment Group n9831 Adjuvant Trastuzumab Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW192

A conversation with Eugene Braunwald. Interview by Ushma S. Neill.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW192

A CD8+ T cell transcription signature predicts prognosis in autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW192

Robust enumeration of cell subsets from tissue expression profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW192

NCBI GEO: archive for functional genomics data sets--update

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW192

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW192

A bioinformatical and functional approach to identify novel strategies for chemoprevention of colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW192

Gene expression analysis identifies global gene dosage sensitivity in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW192

American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW192

Repeated observation of breast tumor subtypes in independent gene expression data sets

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW192

Supervised risk predictor of breast cancer based on intrinsic subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW192

The molecular portraits of breast tumors are conserved across microarray platforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW192

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW192

Gene modules and response to neoadjuvant chemotherapy in breast cancer subtypes: a pooled analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW192

FOXP3 expression and overall survival in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW192

Ipilimumab-dependent cell-mediated cytotoxicity of regulatory T cells ex vivo by nonclassical monocytes in melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW192

Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW192

Macrophages, innate immunity and cancer: balance, tolerance, and diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW192

Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW192

The presence of stromal mast cells identifies a subset of invasive breast cancers with a favorable prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW192

Stromal mast cells in invasive breast cancer are a marker of favourable prognosis: a study of 4,444 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW192

The significant role of mast cells in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW192

Natural killer cells regulate diverse T cell responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW192

T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW192

Tumor-induced changes in the phenotype of blood-derived and tumor-associated T cells of early stage breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW192

Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW192

Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW192

Quantification of Regulatory T Cells Enables the Identification of High-Risk Breast Cancer Patients and Those at Risk of Late Relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW192

A low number of tumor-infiltrating FOXP3-positive cells during primary systemic chemotherapy correlates with favorable anti-tumor response in patients with breast cancer

21 January 2018

1 reference

12 December 2020

Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma

1 reference

12 December 2020

Mast cells in breast cancer

1 reference

12 December 2020

Prognostic significance of FOXP3+ tumor-infiltrating lymphocytes in breast cancer depends on estrogen receptor and human epidermal growth factor receptor-2 expression status and concurrent cytotoxic T-cell infiltration

1 reference

12 December 2020

CD8⁺ cytotoxic T cell and FOXP3⁺ regulatory T cell infiltration in relation to breast cancer survival and molecular subtypes

1 reference

12 December 2020

The prognostic landscape of genes and infiltrating immune cells across human cancers

1 reference

12 December 2020

Mast cells in invasive ductal breast cancer: different behavior in high and minimum hormone-receptive cancers.

1 reference

12 December 2020

CD4⁺ follicular helper T cell infiltration predicts breast cancer survival

1 reference

12 December 2020

Biological Processes Associated with Breast Cancer Clinical Outcome Depend on the Molecular Subtypes

1 reference

12 December 2020

Identifiers

DOI

10.1093/JNCI/DJW192

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27737921%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27737921%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

1 reference